Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression.
about
Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancerSelective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal CancerImmunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma.Promotion of lung tumor growth by interleukin-17IL-17A promotes the migration and invasiveness of cervical cancer cells by coordinately activating MMPs expression via the p38/NF-κB signal pathway.Human umbilical cord mesenchymal stem cells promote carcinoma growth and lymph node metastasis when co-injected with esophageal carcinoma cells in nude mice.Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expressionElevated pretherapy serum IL17 in primary hepatocellular carcinoma patients correlate to increased risk of early recurrence after curative hepatectomy.Prognostic significance of interleukin 17 in cancer: a meta-analysis.The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization.Elevated expression levels of androgen receptors and matrix metalloproteinase-2 and -9 in 30 cases of hepatocellular carcinoma compared with adjacent tissues as predictors of cancer invasion and stagingCapn4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor-κB-induced matrix metalloproteinase 2 expressionEffects of benzo[a]pyrene exposure on human hepatocellular carcinoma cell angiogenesis, metastasis, and NF-κB signaling.Knockdown of autophagy-related gene LC3 enhances the sensitivity of HepG2 cells to epirubicinInterleukin 17A promotes gastric cancer invasiveness via NF-κB mediated matrix metalloproteinases 2 and 9 expression.Human colon carcinogenesis is associated with increased interleukin-17-driven inflammatory responses.Inhibition of IL-17A suppresses enhanced-tumor growth in low dose pre-irradiated tumor bedsComprehensive Evaluation of Nuclear Factor-κΒ Expression Patterns in Non-Small Cell Lung Cancer.Network-Based Analysis of Nutraceuticals in Human Hepatocellular Carcinomas Reveals Mechanisms of Chemopreventive ActionPatients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours.Beneficial Effects of Ocimum gratissimum Aqueous Extract on Rats with CCl(4)-Induced Acute Liver InjuryInterleukin-23 Facilitates Thyroid Cancer Cell Migration and Invasion by Inhibiting SOCS4 Expression via MicroRNA-25.New Approaches for Studying Alcoholic Liver DiseaseFlotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathwaysNuclear HDAC6 inhibits invasion by suppressing NF-κB/MMP2 and is inversely correlated with metastasis of non-small cell lung cancer.High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinomaThe role of IL-17 signaling in regulation of the liver-brain axis and intestinal permeability in Alcoholic Liver Disease.Aurora-A modulates MMP-2 expression via AKT/NF-κB pathway in esophageal squamous cell carcinoma cells.Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines.IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2.S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cellsNEK2 serves as a prognostic biomarker for hepatocellular carcinoma.Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway.Protein Arginine Methyltransferases (PRMTs): promising targets for the treatment of pulmonary disorders.Tumor microenviroment and hepatocellular carcinoma metastasis.IL-17A in hepatitis B infection: friend or foe?Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myelomaInterleukin-17F expression is elevated in hepatitis C patients with fibrosis and hepatocellular carcinoma.PDCD5 transfection increases cisplatin sensitivity and decreases invasion in hepatic cancer cells.
P2860
Q26781520-9F46E69F-C8EE-478E-A8B9-20CC6F899848Q27306938-2CCF610A-3C5D-44A6-857A-371B04EA9C60Q34187221-B47ADB11-A630-4695-A735-C118D039409DQ34201267-75D1993D-C9F0-4174-8A1F-DEABF6430848Q34254057-9329477D-DBA9-45CF-AFB3-023DBCCA554FQ34305853-19F7E745-6868-4DAD-8AE0-7C1B4E7082E9Q34388854-2D62BF7B-41A1-4A18-BEE8-69E1BBE7D62FQ34438689-DDC36BD3-4B83-458A-866B-9A6FA765A369Q34506935-B98CF21F-C094-4EBA-AA5A-FC97CD0D3015Q34547722-69E8FC5D-84B6-46CE-8CF7-65E130AE1032Q35000987-05D8B8B6-875F-437E-B2FA-392CE0EB5C2AQ35048503-3966D14C-E73C-4875-A6C0-03DDEDE2E526Q35051827-77DEFC67-BC87-43DC-95DE-F670FCF9B784Q35144658-E629238F-606D-4AF2-8F2F-C599B2DE29BEQ35159686-3B593FC1-ACEF-4B4B-8E9A-CF749361128AQ35182990-41C952E5-5C1D-4615-A11B-2C19A7570121Q35209789-ABD9A809-14B3-44DF-9C0F-E56BAF54D83FQ35236833-1F65C06F-D30B-4E8A-900E-81A233A72B0EQ35683345-6F298F58-21AC-432A-861A-75B8C3CCA332Q35861710-A20AF293-D835-48AD-BF6C-5D529C4C3F6CQ36045340-B8D52D43-15D4-4BCE-A55D-725ABAF1AABEQ36077581-C3E398C9-8759-40BC-854B-8387834D129AQ36121973-54F9AAEA-A8A5-46D2-BDB6-06180BEF82D4Q36288405-72BD11DA-6E2E-4E3D-A5F6-9DAAF0834841Q36288650-95ECB4D6-A1AE-45B5-9459-39EE5FF96EFAQ36557560-14C74609-00F1-4148-B479-85A4E36C53BFQ36753243-59CED54E-1035-49B1-A677-85FAA82DCF73Q36931974-94E139B1-6416-49BD-B8F9-7AA10379D909Q37020076-66BCAC88-1DE4-4FA0-B08D-24820AA6D020Q37115310-2A913EA2-4DC6-4163-A8EA-AC8E2D87534AQ37376363-637CA7A6-AC09-4EEB-994E-1526EC517084Q37462411-C404BFBF-CB1A-4426-91C9-BF5C3EE67F93Q37588101-0960FF18-339F-4691-B242-F3F8B66B4261Q37701659-4C1B9AB6-631B-45ED-80C0-E3C61B2E9AD2Q38064312-8FBB9E3F-9018-46A0-BF8D-AAB42FE1B7A3Q38121570-D77A5293-F490-40A6-9E89-9E21003DBD73Q38188499-A7E6F9DD-D03A-4AF0-A919-D50CB9ACC7A3Q38255161-2DB40C5F-1433-40D9-96F8-715ADCDB1BCBQ38645528-5E52BA9E-5BC1-47C4-8428-9C3DB8F7F081Q38936648-E593D227-D94F-452A-ABEE-9079DF0210AC
P2860
Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Interleukin 17A promotes hepat ...... roteinases 2 and 9 expression.
@ast
Interleukin 17A promotes hepat ...... roteinases 2 and 9 expression.
@en
type
label
Interleukin 17A promotes hepat ...... roteinases 2 and 9 expression.
@ast
Interleukin 17A promotes hepat ...... roteinases 2 and 9 expression.
@en
prefLabel
Interleukin 17A promotes hepat ...... roteinases 2 and 9 expression.
@ast
Interleukin 17A promotes hepat ...... roteinases 2 and 9 expression.
@en
P2093
P2860
P50
P1433
P1476
Interleukin 17A promotes hepat ...... proteinases 2 and 9 expression
@en
P2093
George Ka-Kit Lau
Sui-sui Dong
Xiao-Ru Huang
P2860
P304
P356
10.1371/JOURNAL.PONE.0021816
P407
P577
2011-07-07T00:00:00Z